YUTOPAR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Yutopar, and when can generic versions of Yutopar launch?
Yutopar is a drug marketed by Astrazeneca and is included in two NDAs.
The generic ingredient in YUTOPAR is ritodrine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the ritodrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for YUTOPAR?
- What are the global sales for YUTOPAR?
- What is Average Wholesale Price for YUTOPAR?
Summary for YUTOPAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 27 |
Clinical Trials: | 1 |
Patent Applications: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | YUTOPAR at DailyMed |
![YUTOPAR drug patent expirations Drug patent expirations by year for YUTOPAR](/p/graph/s/t/YUTOPAR-patent-expirations.png)
Recent Clinical Trials for YUTOPAR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cairo University | Phase 4 |
US Patents and Regulatory Information for YUTOPAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-002 | Sep 27, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astrazeneca | YUTOPAR | ritodrine hydrochloride | TABLET;ORAL | 018555-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for YUTOPAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca | YUTOPAR | ritodrine hydrochloride | TABLET;ORAL | 018555-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca | YUTOPAR | ritodrine hydrochloride | INJECTABLE;INJECTION | 018580-002 | Sep 27, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for YUTOPAR
See the table below for patents covering YUTOPAR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
France | 4404 | ⤷ Sign Up | |
Belgium | 660244 | ⤷ Sign Up | |
Austria | 264502 | ⤷ Sign Up | |
Mexico | 6726 | ⤷ Sign Up | |
Germany | 1293782 | 1-(4-Hydroxyphenyl)-2-[2-(4-hydroxyphenyl)-aethylamino]-propanol, dessen physiologisch vertraeglichen Salze und Verfahren zu deren Herstellung | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |